New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


My Perfect Dish lead

Recipes & Nutrition

Mouth-watering Michelin-starred meals for people with Parkinson’s

Delicious specialised recipes that meet your Parkinson's dietary needs

READ MORE

Women and Parkinson's

“We do ourselves an injustice by just suffering through it”

Richelle Flanagan on connecting with the Parkinson’s disease community

READ MORE
A woman smells a purple orchid.

Advances

How a new smell test could help diagnose Parkinson’s disease

The new solution could help with early detection

READ MORE